Mallinckrodt
-
Malvern-Based Endo Progresses Toward Mallinckrodt Merger Completion
Malvern-based Endo and Mallinckrodt have made significant progress toward the completion of their proposed $6.7 billion merger, writes John George for the Philadelphia Business Journal. …
-
Malvern-Based Endo Approves $3.5M in Retention Bonuses for Executives Ahead of Merger
Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with global specialty pharmaceutical firm Mallinckrodt,…
-
Malvern’s Endo Enters Into Agreement to Merge with Mallinckrodt in $6 Billion Deal
Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical company at $6.7 billion, writes John George…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
